Cellular adaptive response to glutathione depletion modulates endothelial dysfunction triggered by TNF-α

Toxicology Letters

Volumn 207, Issue 3, 2011, Pages 291-297

  Speciale, Antonio ^a   Anwar, Sirajudheen ^a   Ricciardi, Elisabetta ^a   Chirafisi, Joselita ^a   Saija, Antonella ^a   Cimino, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Adaptive response; Antioxidant responsive element; Endothelial dysfunction; Nrf2; Oxidative stress

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL COMMUNICATION; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ADAPTATION, PHYSIOLOGICAL; BLOTTING, WESTERN; BUTHIONINE SULFOXIMINE; CELL ADHESION MOLECULES; GLUTATHIONE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054694589     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.09.017     Document Type: Article

References (33)

1. Antoniades C., Antonopoulos A.S., Bendall J.K., Channon K.M. Targeting redox signaling in the vascular wall: from basic science to clinical practice. Curr. Pharm. Des. 2009, 15:329-342.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
3. Canali R., Ambra R., Stelitano C., Mattivi F., Scaccini C., Virgili F. A novel model to study the biological effects of red wine at the molecular level. Br. J. Nutr. 2007, 97:1053-1058.
4. Cassie S., Masterson M.F., Polukoshko A., Viskovic M.M., Tibbles L.A. Ischemia/reperfusion induces the recruitment of leukocytes from whole blood under flow conditions. Free Radic. Biol. Med. 2004, 36:1102-1111.
5. Chen K.H., Reece L.M., Leary J.F. Mitochondrial glutathione modulates TNF-alpha-induced endothelial cell dysfunction. Free Radic. Biol. Med. 1999, 27:100-109.
6. Chen X.L., Dodd G., Thomas S., Zhang X., Wasserman M.A., Rovin B.H., Kunsch C. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H1862-H1870.
7. Csiszar A., Wang M., Lakatta E.G., Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J. Appl. Physiol. 2008, 105:1333-1341.
8. Hansson G.K., Robertson A.K., Soderberg-Naucler C. Inflammation and atherosclerosis. Annu. Rev. Pathol. 2006, 1:297-329.
9. Harman D. Aging: a theory based on free-radical and radiation-chemistry. J. Gerontol. 1956, 11:298-300.
10. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
11. Jaffe E., Nachmann R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
12. Kim A.N., Jeon W.K., Lee J.J., Kim B.C. Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radic. Biol. Med. 2010, 49:323-331.
13. Kokura S., Wolf R.E., Yoshikawa T., Granger D.N. Molecular mechanisms of neutrophil-endothelial cell adhesion induced by redox imbalance. Circ. Res. 1999, 84:516-524.
14. Lau A., Villeneuve N.F., Sun Z., Wong P.K., Zhang D.D. Dual roles of Nrf2 in cancer. Pharmacol. Res. 2008, 58:262-270.
15. Lee H.R., Cho J.M., Shin D.H., Yong C.S., Choi H.G., Wakabayashi N., Kwak M.K. Adaptive response to GSH depletion and resistance to l-buthionine-(S,R)-sulfoximine: involvement of Nrf2 activation. Mol. Cell. Biochem. 2008, 318:23-31.
16. Lee J.H., Zhou H.Y., Cho S.Y., Kim Y.S., Lee Y.S., Jeong C.S. Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Arch. Pharm. Res. 2007, 30:1318-1327.
17. Limón-Pacheco J.H., Hernández N.A., Fanjul-Moles M.L., Gonsebatt M.E. Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice. Free Radic. Biol. Med. 2007, 43:1335-1347.
18. Liu G.H., Qu J., Shen X. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim. Biophys. Acta 2008, 1783:713-727.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2008, 25:402-408.
20. Mattson M.P. Hormesis defined. Ageing Res. Rev. 2001, 7:1-7.
21. Nguyen T., Nioi P., Pickett C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009, 284:13291-13295.
22. Pi J., Bai Y., Reece J.M., Williams J., Liu D., Freeman M.L., Fahl W.E., Shugar D., Liu J., Qu W., Collins S., Waalkes M.P. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 2007, 42:1797-1806.
23. Speciale A., Canali R., Chirafisi J., Saija A., Virgili F., Cimino F. Cyanidin-3-O-glucoside protection against TNF-α-induced endothelial dysfunction: involvement of nuclear factor-κB signaling. J. Agric. Food Chem. 2010, 58:12048-12054.
24. Speciale A., Chirafisi J., Saija A., Cimino F. Nutritional antioxidants and adaptive cell responses: an update. Curr. Mol. Med. 2011, 11(9). in press.
25. Sprague A.H., Khalil R.A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 2009, 78:539-552.
26. Surh Y.J., Na H.K. NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr. 2008, 2:313-317.
27. Takabe W., Warabi E., Noguchi N. Anti-atherogenic effect of laminar shear stress via Nrf2 activation. Antioxid. Redox Signal. 2010, 10.1089/ars.2010.3433.
28. Talalay P., Dinkova-Kostova A.T., Holtzclaw W.D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzyme Regul. 2003, 43:121-134.
29. Trombetta D., Cimino F., Cristani M., Mandalari G., Saija A., Ginestra G., Speciale A., Chirafisi J., Bisignano G., Waldron K., Narbad A., Faulds C.B. In vitro protective effects of two extracts from bergamot peels on human endothelial cells exposed to tumor necrosis factor-alpha. J. Agric. Food Chem. 2010, 58:8430-8436.
30. Xu C., Yuan X., Pan Z., Shen G., Kim J.H., Yu S., Khor T.O., Li W., Ma J., Kong A.N. Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol. Cancer Ther. 2006, 5:1918-1926.
31. Zakkar M., Van der Heiden K., Luong le A., Chaudhury H., Cuhlmann S., Hamdulay S.S., Krams R., Edirisinghe I., Rahman I., Carlsen H., Haskard D.O., Mason J.C., Evans P.C. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1851-1857.
32. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 2006, 38:769-789.
33. Zhang Q., Pi J., Woods C.G., Andersen M.E. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol. Appl. Pharmacol. 2010, 244:84-97.